Results 1 to 10 of about 12,043,843 (293)

[Antihypertensive treatment for kidney transplant recipients]. [PDF]

Urologie
BACKGROUND The comparative effects of specific blood pressure (BP) lowering treatments on patient-important outcomes following kidney transplantation are uncertain.
Schneidewind L.
europepmc   +3 more sources

The association between antihypertensive treatment and serious adverse events by age and frailty: A cohort study. [PDF]

PLoS Med, 2023
Background Antihypertensives are effective at reducing the risk of cardiovascular disease, but limited data exist quantifying their association with serious adverse events, particularly in older people with frailty.
Sheppard JP, Koshiaris C, Stevens R, Lay-Flurrie S, Banerjee A, Bellows BK, Clegg A, Hobbs FDR, Payne RA, Swain S, Usher-Smith JA, McManus RJ.   +11 more
europepmc   +2 more sources

Pharmacomicrobiomics: Exploiting the Drug-Microbiota Interactions in Antihypertensive Treatment. [PDF]

Front Med (Lausanne), 2021
Hypertension is a leading risk factor for cardiovascular diseases and can reduce life expectancy. Owing to the widespread use of antihypertensive drugs, patients with hypertension have improved blood pressure control over the past few decades.
Chen HQ, Gong JY, Xing K, Liu MZ, Ren H, Luo JQ.   +5 more
europepmc   +2 more sources

Screening for non-adherence to antihypertensive treatment as a part of the diagnostic pathway to renal denervation [PDF]

Journal of Human Hypertension, 2015
Renal denervation is a potential therapeutic option for resistant hypertension. A thorough clinical assessment to exclude reversible/spurious causes of resistance to antihypertensive therapy is required prior to this procedure.
Prashanth Patel, Pankaj Gupta, Christobelle White, Adrian G. Stanley, Bryan Williams, Maciej Tomaszewski   +5 more
openalex   +2 more sources

Association between antihypertensive treatment and adverse events: systematic review and meta-analysis

British medical journal, 2021
Objective To examine the association between antihypertensive treatment and specific adverse events. Design Systematic review and meta-analysis. Eligibility criteria Randomised controlled trials of adults receiving antihypertensives compared with placebo
A. Albasri, M. Hattle, Constantinos Koshiaris, Anna Dunnigan, Ben Paxton, Sarah Emma Fox, Margaret Smith, Lucinda Archer, Brooke Levis, Rupert A Payne, Richard D Riley, N. Roberts, K. Snell, S. Lay-Flurrie, J. Usher-Smith, FD RichardStevens, Richard Hobbs, Richard J. McManus, James P Sheppard   +18 more
semanticscholar   +1 more source

Impact of Chronic Hypertension and Antihypertensive Treatment on Adverse Perinatal Outcomes: Systematic Review and Meta‐Analysis

Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2021
Background Maternal chronic hypertension is associated with adverse pregnancy outcomes. Previous studies examined the association between either chronic hypertension or antihypertensive treatment and adverse pregnancy outcomes. We aimed to synthesize the
Sukainah Y. Al Khalaf, É. O’Reilly, P. Barrett, Debora F B Leite, L. Pawley, F. McCarthy, A. Khashan   +6 more
semanticscholar   +1 more source

The relation between antihypertensive treatment and progression of cerebral small vessel disease

Medicine, 2021
Background: Cerebral small vessel disease is relevant to hypertension. We tried to figure out whether antihypertensive treatment is beneficial for this disease.
Chen Su, Hao Wu, Xiaoyu Yang, B. Zhao, R. Zhao   +4 more
semanticscholar   +1 more source

Association between baseline blood pressure and the incidence of lenvatinib‐induced hypertension in patients with thyroid cancer

Cancer Medicine, 2023
Background Hypertension is the most frequently occurring adverse event of lenvatinib, recognized relatively early in its course. However, the trend in blood pressure after the initiation of lenvatinib and the outcomes with antihypertensive treatment are ...
Yuma Shibutani, Kazuko Tajiri, Shinya Suzuki, Tomohiro Enokida, Atsunobu Sagara, Susumu Okano, Takao Fujisawa, Fumiaki Sato, Tetsuro Yumoto, Motohiko Sano, Toshikatsu Kawasaki, Makoto Tahara   +11 more
doaj   +1 more source

The Impact of the Renin-Angiotensin-Aldosterone System on Inflammation, Coagulation, and Atherothrombotic Complications, and to Aggravated COVID-19

Frontiers in Pharmacology, 2021
Atherosclerosis is considered a disease caused by a chronic inflammation, associated with endothelial dysfunction, and several mediators of inflammation are up-regulated in subjects with atherosclerotic disease.
M. Ekholm, T. Kahan
doaj   +1 more source

Magnitude of Systolic Blood Pressure Reduction and Early Achieved Blood Pressure and Clinical Outcomes After Acute Ischemic Stroke

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background We aimed to evaluate the relationships between the magnitude of systolic blood pressure (SBP) reduction and achieved SBP in the acute phase of ischemic stroke onset and subsequent clinical outcomes.
Yujia Zhai, Mengyao Shi, Yang Liu, Yanbo Peng, Zhengbao Zhu, Aili Wang, Hao Peng, Tian Xu, Jing Chen, Tan Xu, Yonghong Zhang, Jiang He, Chongke Zhong   +12 more
doaj   +1 more source